BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19409179)

  • 1. [Human embryonic-stem-cell-derived striatal graft for Huntington's disease cell therapy].
    Aubry L; Peschanski M; Perrier AL
    Med Sci (Paris); 2009 Apr; 25(4):333-5. PubMed ID: 19409179
    [No Abstract]   [Full Text] [Related]  

  • 2. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation.
    Capetian P; Knoth R; Maciaczyk J; Pantazis G; Ditter M; Bokla L; Landwehrmeyer GB; Volk B; Nikkhah G
    Neuroscience; 2009 May; 160(3):661-75. PubMed ID: 19254752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington's disease.
    Bantubungi K; Blum D; Cuvelier L; Wislet-Gendebien S; Rogister B; Brouillet E; Schiffmann SN
    Mol Cell Neurosci; 2008 Mar; 37(3):454-70. PubMed ID: 18083596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.
    Watts C; Brasted PJ; Dunnett SB
    Exp Neurol; 2000 May; 163(1):85-97. PubMed ID: 10785447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats.
    Aubry L; Bugi A; Lefort N; Rousseau F; Peschanski M; Perrier AL
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16707-12. PubMed ID: 18922775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of human striatal anlagen after transplantation in a patient with Huntington's disease.
    Gallina P; Paganini M; Lombardini L; Saccardi R; Marini M; De Cristofaro MT; Pinzani P; Salvianti F; Crescioli C; Di Rita A; Bucciantini S; Mechi C; Sarchielli E; Moretti M; Piacentini S; Gritti G; Bosi A; Sorbi S; Orlandini G; Vannelli GB; Di Lorenzo N
    Exp Neurol; 2008 Sep; 213(1):241-4. PubMed ID: 18601923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
    Gaura V; Bachoud-Lévi AC; Ribeiro MJ; Nguyen JP; Frouin V; Baudic S; Brugières P; Mangin JF; Boissé MF; Palfi S; Cesaro P; Samson Y; Hantraye P; Peschanski M; Remy P
    Brain; 2004 Jan; 127(Pt 1):65-72. PubMed ID: 14607797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell transplantation for Huntington's disease.
    Sanberg PR; Koutouzis TK; Freeman TB; Emerich DF; Bertino AM; Cahill DW
    Transplant Proc; 1992 Dec; 24(6):3015-6. PubMed ID: 1361271
    [No Abstract]   [Full Text] [Related]  

  • 9. Embryonic stem cell-derived L1 overexpressing neural aggregates enhance recovery in Parkinsonian mice.
    Cui YF; Hargus G; Xu JC; Schmid JS; Shen YQ; Glatzel M; Schachner M; Bernreuther C
    Brain; 2010 Jan; 133(Pt 1):189-204. PubMed ID: 19995872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal allografts in patients with Huntington's disease: impact of diminished astrocytes and vascularization on graft viability.
    Cisbani G; Freeman TB; Soulet D; Saint-Pierre M; Gagnon D; Parent M; Hauser RA; Barker RA; Cicchetti F
    Brain; 2013 Feb; 136(Pt 2):433-43. PubMed ID: 23378216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).
    Quinn N; Brown R; Craufurd D; Goldman S; Hodges J; Kieburtz K; Lindvall O; MacMillan J; Roos R
    Mov Disord; 1996 Mar; 11(2):143-50. PubMed ID: 8684383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Lee ST; Chu K; Jung KH; Im WS; Park JE; Lim HC; Won CH; Shin SH; Lee SK; Kim M; Roh JK
    Ann Neurol; 2009 Nov; 66(5):671-81. PubMed ID: 19938161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. We need something better, and we need it now: fetal striatal transplantation in Huntington's disease?
    Greenamyre JT; Shoulson I
    Neurology; 2002 Mar; 58(5):675-6. PubMed ID: 11889226
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum.
    Darsalia V; Kallur T; Kokaia Z
    Eur J Neurosci; 2007 Aug; 26(3):605-14. PubMed ID: 17686040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of transplant efficiency between spontaneously derived and noggin-primed human embryonic stem cell neural precursors in the quinolinic acid rat model of Huntington's disease.
    Vazey EM; Dottori M; Jamshidi P; Tomas D; Pera MF; Horne M; Connor B
    Cell Transplant; 2010; 19(8):1055-62. PubMed ID: 20350346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation.
    Watts C; Dunnett SB; Rosser AE
    Exp Neurol; 1997 Nov; 148(1):271-80. PubMed ID: 9398469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.